COVID-19 Impact on Global Visceral Pain Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 97 pages | ID: C5BCE997ABB5EN
QYResearch

Abstracts

This report focuses on the global Visceral Pain Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Visceral Pain Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Addex Therapeutics Ltd
• Astellas Pharma Inc.
• Chromocell Corporation
• GIcare Pharma Inc
• Grunenthal GmbH
• Medestea Research & Production S.p.A.
• Neurim Pharmaceuticals Ltd
• Pfizer Inc.

Market segment by Type, the product can be split into

• HS-665
• CC-8464
• BLU-5937
• APD-371
• Others

Market segment by Application, split into

• In-patient
• Out-patient

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Visceral Pain Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Visceral Pain Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Visceral Pain Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Visceral Pain Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Visceral Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HS-665
  1.4.3 CC-8464
  1.4.4 BLU-5937
  1.4.5 APD-371
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Visceral Pain Treatment Market Share by Application: 2020 VS 2026
  1.5.2 In-patient
  1.5.3 Out-patient
1.6 Coronavirus Disease 2019 (Covid-19): Visceral Pain Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Visceral Pain Treatment Industry
    1.6.1.1 Visceral Pain Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Visceral Pain Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Visceral Pain Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Visceral Pain Treatment Market Perspective (2015-2026)
2.2 Visceral Pain Treatment Growth Trends by Regions
  2.2.1 Visceral Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Visceral Pain Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Visceral Pain Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Visceral Pain Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Visceral Pain Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Visceral Pain Treatment Players by Market Size
  3.1.1 Global Top Visceral Pain Treatment Players by Revenue (2015-2020)
  3.1.2 Global Visceral Pain Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Visceral Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Visceral Pain Treatment Market Concentration Ratio
  3.2.1 Global Visceral Pain Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Visceral Pain Treatment Revenue in 2019
3.3 Visceral Pain Treatment Key Players Head office and Area Served
3.4 Key Players Visceral Pain Treatment Product Solution and Service
3.5 Date of Enter into Visceral Pain Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Visceral Pain Treatment Historic Market Size by Type (2015-2020)
4.2 Global Visceral Pain Treatment Forecasted Market Size by Type (2021-2026)

5 VISCERAL PAIN TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Visceral Pain Treatment Market Size by Application (2015-2020)
5.2 Global Visceral Pain Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Visceral Pain Treatment Market Size (2015-2020)
6.2 Visceral Pain Treatment Key Players in North America (2019-2020)
6.3 North America Visceral Pain Treatment Market Size by Type (2015-2020)
6.4 North America Visceral Pain Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Visceral Pain Treatment Market Size (2015-2020)
7.2 Visceral Pain Treatment Key Players in Europe (2019-2020)
7.3 Europe Visceral Pain Treatment Market Size by Type (2015-2020)
7.4 Europe Visceral Pain Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Visceral Pain Treatment Market Size (2015-2020)
8.2 Visceral Pain Treatment Key Players in China (2019-2020)
8.3 China Visceral Pain Treatment Market Size by Type (2015-2020)
8.4 China Visceral Pain Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Visceral Pain Treatment Market Size (2015-2020)
9.2 Visceral Pain Treatment Key Players in Japan (2019-2020)
9.3 Japan Visceral Pain Treatment Market Size by Type (2015-2020)
9.4 Japan Visceral Pain Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Visceral Pain Treatment Market Size (2015-2020)
10.2 Visceral Pain Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Visceral Pain Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Visceral Pain Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Visceral Pain Treatment Market Size (2015-2020)
11.2 Visceral Pain Treatment Key Players in India (2019-2020)
11.3 India Visceral Pain Treatment Market Size by Type (2015-2020)
11.4 India Visceral Pain Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Visceral Pain Treatment Market Size (2015-2020)
12.2 Visceral Pain Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Visceral Pain Treatment Market Size by Type (2015-2020)
12.4 Central & South America Visceral Pain Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Addex Therapeutics Ltd
  13.1.1 Addex Therapeutics Ltd Company Details
  13.1.2 Addex Therapeutics Ltd Business Overview and Its Total Revenue
  13.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Introduction
  13.1.4 Addex Therapeutics Ltd Revenue in Visceral Pain Treatment Business (2015-2020))
  13.1.5 Addex Therapeutics Ltd Recent Development
13.2 Astellas Pharma Inc.
  13.2.1 Astellas Pharma Inc. Company Details
  13.2.2 Astellas Pharma Inc. Business Overview and Its Total Revenue
  13.2.3 Astellas Pharma Inc. Visceral Pain Treatment Introduction
  13.2.4 Astellas Pharma Inc. Revenue in Visceral Pain Treatment Business (2015-2020)
  13.2.5 Astellas Pharma Inc. Recent Development
13.3 Chromocell Corporation
  13.3.1 Chromocell Corporation Company Details
  13.3.2 Chromocell Corporation Business Overview and Its Total Revenue
  13.3.3 Chromocell Corporation Visceral Pain Treatment Introduction
  13.3.4 Chromocell Corporation Revenue in Visceral Pain Treatment Business (2015-2020)
  13.3.5 Chromocell Corporation Recent Development
13.4 GIcare Pharma Inc
  13.4.1 GIcare Pharma Inc Company Details
  13.4.2 GIcare Pharma Inc Business Overview and Its Total Revenue
  13.4.3 GIcare Pharma Inc Visceral Pain Treatment Introduction
  13.4.4 GIcare Pharma Inc Revenue in Visceral Pain Treatment Business (2015-2020)
  13.4.5 GIcare Pharma Inc Recent Development
13.5 Grunenthal GmbH
  13.5.1 Grunenthal GmbH Company Details
  13.5.2 Grunenthal GmbH Business Overview and Its Total Revenue
  13.5.3 Grunenthal GmbH Visceral Pain Treatment Introduction
  13.5.4 Grunenthal GmbH Revenue in Visceral Pain Treatment Business (2015-2020)
  13.5.5 Grunenthal GmbH Recent Development
13.6 Medestea Research & Production S.p.A.
  13.6.1 Medestea Research & Production S.p.A. Company Details
  13.6.2 Medestea Research & Production S.p.A. Business Overview and Its Total Revenue
  13.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Introduction
  13.6.4 Medestea Research & Production S.p.A. Revenue in Visceral Pain Treatment Business (2015-2020)
  13.6.5 Medestea Research & Production S.p.A. Recent Development
13.7 Neurim Pharmaceuticals Ltd
  13.7.1 Neurim Pharmaceuticals Ltd Company Details
  13.7.2 Neurim Pharmaceuticals Ltd Business Overview and Its Total Revenue
  13.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Introduction
  13.7.4 Neurim Pharmaceuticals Ltd Revenue in Visceral Pain Treatment Business (2015-2020)
  13.7.5 Neurim Pharmaceuticals Ltd Recent Development
13.8 Pfizer Inc.
  13.8.1 Pfizer Inc. Company Details
  13.8.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.8.3 Pfizer Inc. Visceral Pain Treatment Introduction
  13.8.4 Pfizer Inc. Revenue in Visceral Pain Treatment Business (2015-2020)
  13.8.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Visceral Pain Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Visceral Pain Treatment Revenue
Table 3. Ranking of Global Top Visceral Pain Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Visceral Pain Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HS-665
Table 6. Key Players of CC-8464
Table 7. Key Players of BLU-5937
Table 8. Key Players of APD-371
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Visceral Pain Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Visceral Pain Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Visceral Pain Treatment Players to Combat Covid-19 Impact
Table 15. Global Visceral Pain Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Visceral Pain Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Visceral Pain Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Visceral Pain Treatment Market Share by Regions (2015-2020)
Table 19. Global Visceral Pain Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Visceral Pain Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Visceral Pain Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Visceral Pain Treatment Players
Table 26. Global Visceral Pain Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Visceral Pain Treatment Market Share by Players (2015-2020)
Table 28. Global Top Visceral Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Visceral Pain Treatment as of 2019)
Table 29. Global Visceral Pain Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Visceral Pain Treatment Product Solution and Service
Table 32. Date of Enter into Visceral Pain Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Visceral Pain Treatment Market Size Share by Type (2015-2020)
Table 36. Global Visceral Pain Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Visceral Pain Treatment Market Size Share by Application (2015-2020)
Table 38. Global Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Visceral Pain Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 42. North America Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Visceral Pain Treatment Market Share by Type (2015-2020)
Table 44. North America Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Visceral Pain Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 48. Europe Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Visceral Pain Treatment Market Share by Type (2015-2020)
Table 50. Europe Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Visceral Pain Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 54. China Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Visceral Pain Treatment Market Share by Type (2015-2020)
Table 56. China Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Visceral Pain Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 60. Japan Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Visceral Pain Treatment Market Share by Type (2015-2020)
Table 62. Japan Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Visceral Pain Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 66. Southeast Asia Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Visceral Pain Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Visceral Pain Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 72. India Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Visceral Pain Treatment Market Share by Type (2015-2020)
Table 74. India Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Visceral Pain Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Visceral Pain Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Visceral Pain Treatment Market Share (2019-2020)
Table 78. Central & South America Visceral Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Visceral Pain Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Visceral Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Visceral Pain Treatment Market Share by Application (2015-2020)
Table 82. Addex Therapeutics Ltd Company Details
Table 83. Addex Therapeutics Ltd Business Overview
Table 84. Addex Therapeutics Ltd Product
Table 85. Addex Therapeutics Ltd Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 86. Addex Therapeutics Ltd Recent Development
Table 87. Astellas Pharma Inc. Company Details
Table 88. Astellas Pharma Inc. Business Overview
Table 89. Astellas Pharma Inc. Product
Table 90. Astellas Pharma Inc. Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 91. Astellas Pharma Inc. Recent Development
Table 92. Chromocell Corporation Company Details
Table 93. Chromocell Corporation Business Overview
Table 94. Chromocell Corporation Product
Table 95. Chromocell Corporation Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 96. Chromocell Corporation Recent Development
Table 97. GIcare Pharma Inc Company Details
Table 98. GIcare Pharma Inc Business Overview
Table 99. GIcare Pharma Inc Product
Table 100. GIcare Pharma Inc Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 101. GIcare Pharma Inc Recent Development
Table 102. Grunenthal GmbH Company Details
Table 103. Grunenthal GmbH Business Overview
Table 104. Grunenthal GmbH Product
Table 105. Grunenthal GmbH Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 106. Grunenthal GmbH Recent Development
Table 107. Medestea Research & Production S.p.A. Company Details
Table 108. Medestea Research & Production S.p.A. Business Overview
Table 109. Medestea Research & Production S.p.A. Product
Table 110. Medestea Research & Production S.p.A. Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 111. Medestea Research & Production S.p.A. Recent Development
Table 112. Neurim Pharmaceuticals Ltd Company Details
Table 113. Neurim Pharmaceuticals Ltd Business Overview
Table 114. Neurim Pharmaceuticals Ltd Product
Table 115. Neurim Pharmaceuticals Ltd Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 116. Neurim Pharmaceuticals Ltd Recent Development
Table 117. Pfizer Inc. Business Overview
Table 118. Pfizer Inc. Product
Table 119. Pfizer Inc. Company Details
Table 120. Pfizer Inc. Revenue in Visceral Pain Treatment Business (2015-2020) (Million US$)
Table 121. Pfizer Inc. Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Visceral Pain Treatment Market Share by Type: 2020 VS 2026
Figure 2. HS-665 Features
Figure 3. CC-8464 Features
Figure 4. BLU-5937 Features
Figure 5. APD-371 Features
Figure 6. Others Features
Figure 7. Global Visceral Pain Treatment Market Share by Application: 2020 VS 2026
Figure 8. In-patient Case Studies
Figure 9. Out-patient Case Studies
Figure 10. Visceral Pain Treatment Report Years Considered
Figure 11. Global Visceral Pain Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Visceral Pain Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Visceral Pain Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Visceral Pain Treatment Market Share by Players in 2019
Figure 16. Global Top Visceral Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Visceral Pain Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Visceral Pain Treatment Revenue in 2019
Figure 18. North America Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Visceral Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Addex Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Addex Therapeutics Ltd Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 27. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Astellas Pharma Inc. Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 29. Chromocell Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Chromocell Corporation Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 31. GIcare Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GIcare Pharma Inc Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 33. Grunenthal GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Grunenthal GmbH Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 35. Medestea Research & Production S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Medestea Research & Production S.p.A. Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 37. Neurim Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Neurim Pharmaceuticals Ltd Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 39. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Pfizer Inc. Revenue Growth Rate in Visceral Pain Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed